PURPOSE: Adjuvant chemotherapy for breast cancer can be associated with a variety of side effects, one of which is the induction of premature menopause in premenopausal patient. Although taxanes have increasingly been used in the adjuvant setting, there has been relatively little published on the frequency of amenorrhea related to their use. PATIENTS AND METHODS: We review records of 159 premenopausal patients receiving adjuvant chemotherapy from our practice. RESULTS: Altogether, 51% of all patients retained menstrual function after chemotherapy. CONCLUSION: It was observed that patients receiving adjuvant anthracycline-based chemotherapy with sequential taxane therapy did not have a higher rate of amenorrhea than those not receiving a taxane.
PURPOSE: Adjuvant chemotherapy for breast cancer can be associated with a variety of side effects, one of which is the induction of premature menopause in premenopausal patient. Although taxanes have increasingly been used in the adjuvant setting, there has been relatively little published on the frequency of amenorrhea related to their use. PATIENTS AND METHODS: We review records of 159 premenopausal patients receiving adjuvant chemotherapy from our practice. RESULTS: Altogether, 51% of all patients retained menstrual function after chemotherapy. CONCLUSION: It was observed that patients receiving adjuvant anthracycline-based chemotherapy with sequential taxane therapy did not have a higher rate of amenorrhea than those not receiving a taxane.
Authors: Rodrigo R Munhoz; Allan A L Pereira; André D Sasse; Paulo M Hoff; Tiffany A Traina; Clifford A Hudis; Ricardo J Marques Journal: JAMA Oncol Date: 2016-01 Impact factor: 31.777
Authors: Pamela N Munster; Amy P Moore; Roohi Ismail-Khan; Charles E Cox; Mensura Lacevic; Margaret Gross-King; Ping Xu; W Bradford Carter; Susan E Minton Journal: J Clin Oncol Date: 2012-01-09 Impact factor: 44.544
Authors: Kathryn J Ruddy; Hao Guo; William Barry; Chau T Dang; Denise A Yardley; Beverly Moy; P Kelly Marcom; Kathy S Albain; Hope S Rugo; Matthew J Ellis; Iuliana Shapira; Antonio C Wolff; Lisa A Carey; Beth A Overmoyer; Clifford Hudis; Ian E Krop; Harold J Burstein; Eric P Winer; Ann H Partridge; Sara M Tolaney Journal: Breast Cancer Res Treat Date: 2015-05-16 Impact factor: 4.872
Authors: Leila Pourali; Ali Taghizadeh Kermani; Mohammad Reza Ghavamnasiri; Fahimeh Khoshroo; Sare Hosseini; Mehdi Asadi; Kazem Anvari Journal: Iran J Cancer Prev Date: 2013
Authors: Theodoros Maltaris; Michael Weigel; Andreas Mueller; Marcus Schmidt; Rudolf Seufert; Franz Fischl; Heinz Koelbl; Ralf Dittrich Journal: Breast Cancer Res Date: 2008-04-29 Impact factor: 6.466
Authors: Martine Berliere; Florence Dalenc; Nathalie Malingret; Anita Vindevogel; Philippe Piette; Henry Roche; Jacques Donnez; Michel Symann; Joseph Kerger; Jean-Pascal Machiels Journal: BMC Cancer Date: 2008-02-21 Impact factor: 4.430